Mammary Gland Secretions Research Articles

The origin of lactation as a water source for parchment-shelled eggs.

Available evidence indicates that mammary gland secretions first evolved in synapsids that laid parchment-shelled eggs. Unlike the rigid-shelled eggs of birds and some other sauropsids, parchment-shelled eggs lose water very rapidly when exposed to ambient air of lower vapor pressure, whether due to differences in relative humidity or to differences in temperature. This precludes endothermic incubation of parchment-shelled eggs in an open nest. Synapsids may have avoided egg desiccation by incubating eggs in a pouch, but this would limit maternal activity. Parchment-shelled eggs are able to take up liquid water across the eggshell. I propose that mammary secretion originally evolved as a means of supplying water to eggs, and as such was essential to the evolution of endothermy among the egg-laying cynodonts that were ancestral to mammals. It is possible that synapsid eggs, like parchment-shelled squamate eggs, were also capable of uptake of some nutrients, such as sodium and ionic calcium. Living monotremes still produce parchment-shelled eggs. The porous eggshell and bilaminar yolk sac membrane of these eggs permit substantial uptake of uterine secretions during the intrauterine period, and might also facilitate uptake of mammary secretions during egg incubation. In its simplest form, mammary secretion may be an ancient trait of egg-laying synapsids, having had an important role long before milk became obligatory for suckling young.

Shedding of porcine reproductive and respiratory syndrome virus in mammary gland secretions of sows.

To document shedding of porcine reproductive and respiratory syndrome (PRRS) virus in mammary gland secretions of experimentally inoculated sows, to evaluate effects of vaccination during gestation on virus shedding during the subsequent lactation, and to evaluate shedding of PRRS virus in milk of sows in commercial herds. 6 sows seronegative for PRRS virus were used for experiment 1, and 2 sows were retained for experiment 2. For experiment 3, 202 sows in commercial herds were used. In experiment 1, 2 sows were inoculated with PRRS virus, 2 sows were vaccinated with modified-live PRRS virus vaccine, and 2 sows served as control pigs. Mammary gland secretions were assayed for PRRS virus. In experiment 2, pregnant vaccinated sows from experiment 1 were vaccinated with another modified-live PRRS virus vaccine. Mammary gland secretions were assayed in the same manner as for experiment 1. For experiment 3, milk collected from 202 sows in commercial herds was assayed for PRRS virus. In experiment 1, PRRS virus was detected in mammary gland secretions of both vaccinated and 1 of 2 virus-inoculated sows. In experiment 2, virus was not detected in samples from either vaccinated sow. In experiment 3, all samples yielded negative results. Naïve sows inoculated late in gestation shed PRRS virus in mammary secretions. Previous vaccination appeared to prevent shedding during the subsequent lactation. Results for samples obtained from sows in commercial herds suggested that virus shedding in mammary gland secretions of such sows is uncommon.

A repeated 28-day oral dose toxicity study of 17alpha-methyltestosterone in rats, based on the 'enhanced OECD Test Guideline 407' for screening the endocrine-disrupting chemicals.

As part of the international validation project to establish the Enhanced OECD Test Guideline 407, we performed a 28-day repeated-dose toxicity study of 17alpha-methyltestosterone, an exogenous androgen agonist. Special attention was paid to the sensitivity of additional parameters for detecting endocrine-related effects of endocrine-disrupting chemicals, based on the existing Test Guideline 407. Seven-week-old Crj:CD(SD)IGS rats were allocated to one of four groups, each consisting of ten males and ten females, and 17alpha-methyltestosterone was administered daily by gavage at doses of 0 (control), 5, 20 and 80 mg/kg body weight per day. Male rats were killed on the day after the 28th administration and females on the day of the diestrus stage during the 4 day period after the 28th administration. Male rats receiving 80 mg/kg 17alpha-methyltestosterone demonstrated decreases in testis and epididymis weights, atrophy of seminiferous tubules and Leydig cells, and degenerated pachytene spermatocytes in the testes and degenerated germ cells in the epididymides as major alterations. Female rats showed abnormal estrous cycles, decreases in ovary and adrenal weights, increase in immature follicles with decreased corpus lutea in the ovaries at doses of 5 mg/kg and higher, as well as atrophy of zona reticularis in the adrenals and increase in mammary gland secretion at 20 mg/kg and above. Dilatation of the lumina and apoptosis of endometrial cells in the uterus, mucinification in the vagina and increase in serum follicle-stimulating hormone were seen with 80 mg/kg. Among the parameters examined in the present experimental system, effects of 17alpha-methyltestosterone on endocrine-related organs were detected in organ weights and histopathological examination of both sexes, and in serum hormones and estrous cycle of females. Based on these results, the no-observed-adverse-effect level (NOAEL) in the present study was estimated to be below 5 mg/kg per day. In particular, effects were most sensitively detected by organ weights and histopathological examination of sexual organs.

Partial purification and characterization of proteins with growth promoting activities from ovine mammary gland secretions

Developmental regulation of growth promoting activities in mammary secretions of pregnant Awassi ewes was defined, and growth factors contained in these secretions were partially purified and characterised. Mammary secretions from pregnant ewes enhanced fibroblast cell (AKR-2B) and mammary cell (CID-9 cell strain) proliferation to levels comparable to that induced by 10% Foetal calf serum. Major milk proteins in mammary secretions collected from pregnant ewes one month prior to lambing up to one week after lambing, were resolved by SDS-PAGE, while gelatinases were resolved by zymography. Gelatinase activity was noted prior to P134 and decreased thereafter to reach a minimum during lactation. This decrease was concomitant with the onset of casein production. It is during this critical developmental period that highest growth promoting activity in mammary secretions was detected. Secretions with highest growth promoting activity were fractionated by ion exchange and gel filtration chromatography. Two heat-resistant, trypsin/chymotrypsin sensitive, growth-promoting activities were characterised. The first, designated ovine mammary derived growth factor-1 (oMDGF-1), had around a 30 kDa molecular weight and eluted at 0.65 M NaCl gradient on cation ion exchange chromatography. The second, oMDGF-2, eluted under gel filtration conditions at a molecular weight of 50 kDa and 150 kDa. oMDGF-1 induced changes in Connexin 43, but not in β-casein mRNA expression by CID-9 mammary cells. In conclusion, growth factor activities in ewe mammary secretions peak during gestation at a period that overlaps maximal gelatinase expression and precedes milk protein synthesis. The factors modulate mammary cell function and may play a role in mammary gland development.

Course of epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) in mammary secretions of the goat during end-pregnancy and early lactation.

The epidermal growth factor (EGF) plays a crucial role in mammogenesis in many species. In ruminants, studies are limited, as EGF does not occur in peripheral plasma and specific analytical systems do not exist. Therefore a heterologous radioimmunoassay based on rhEGF was set up to monitor EGF in mammary gland secretions from goats during end-pregnancy and early lactation. IGF-I was measured with an established radioimmunoassay. Samples were collected from 13 goats for 25 days ante-partum and 25 days post-partum. Mammary gland secretions were obtained ante-partum by removing a small amount of the udder secretions (control half) or milking (stimulated half). Post-partum normal milk samples were collected. Blood samples were drawn by jugular venipuncture for the same period. EGF was found to occur in different molecular weight forms in the mammary glands. For routine measurements these proteins were extracted with acetone and not further separated. IGF-I and EGF concentrations in mammary secretions and similarly IGF-I in blood were high ante-partum and decreased slightly towards birth. IGF-I but not EGF is found in the peripheral plasma. Whereas IGF-I concentrations in blood were quite constant post-partum, IGF-I and EGF dropped in mammary secretions close to the detection limits. The decrease was more pronounced in the stimulated half than in the control half. The data support a synergistic role for EGF and IGF-I for mammogenesis. Both factors are further influenced by the milking stimulus and thus the functional state of the udder.

Structural Characterization of the Fibroblast Growth Factor-binding Protein Purified from Bovine Prepartum Mammary Gland Secretion

A novel heparin-binding protein was purified to homogeneity from bovine prepartum mammary gland secretion using heparin-Sepharose chromatography and reverse-phase high performance liquid chromatography successively. Structural information obtained by N-terminal amino acid sequencing of a series of proteolytically generated peptides permitted the cloning of the corresponding cDNA. The isolated cDNA was 1170 base pairs long and consisted of an 83-base pair 5'-untranslated region followed by a 702-base pair coding region and a 385-base pair 3'-untranslated region. The open reading frame resulted in a protein comprising 234- amino acid residues, including a signal sequence. Instead of Lys(24) as the predicted N terminus, Edman degradation of the native protein revealed N-terminal processing at two sites as follows: a primary site between Arg(31)-Gly(32) and a secondary site between Arg(51)-Ser(52). The amino acid sequence showed a significant similarity with that of human (60%) and mouse (53%) fibroblast growth factor-binding protein (FGF-BP). Accordingly, ligand blotting experiments revealed that bovine FGF-BP bound FGF-2. The theoretical mass of the protein predicted from the cDNA sequence is 22.5 kDa. However, the molecular mass of the purified protein was estimated to 28.6 kDa by mass spectrometry and 36 kDa by electrophoresis. The apparent molecular weight differences are most likely due to post-transcriptional modifications, shown to involve N- and O-glycosylation of Asn(155) and Ser(172), respectively. All 10 cysteine residues in the protein participated in disulfide bonds, and the pattern was identified as Cys(71)-Cys(88), Cys(97)-Cys(130), Cys(106)-Cys(142), Cys(198)-Cys(234), and Cys(214)-Cys(222). As the 10 cysteines of the three known FGF-BPs are positionally conserved, the disulfide bond pattern of bovine FGF-BP may be regarded as representative for the FGF-BP family.

Simulation analysis of substrate utilization in the mammary gland of lactating cows.

A kinetic modelling approach was developed and investigated with the aim of predicting the utilization of major substrates in the mammary gland and milk secretion rates in the lactating cow at varying concentrations of substrate in arterial blood. The model includes kinetic equations of transport and metabolism of glucose, acetate, free amino acids and free fatty acids in secretory cells and a phenomenological description of autoregulation of local blood flow, in which an energy criterion of control has been used. The predicted relationships between the rate of milk secretion and glucose levels in the blood are consistent with experimental results. Differential stimulation of alpha-lactalbumin synthesis causes increments in local blood flow and milk secretion rate in the model. The results of the study suggest that there is no simple relationship between the level of substrates in the blood and milk yield and contents of fat and protein in milk. This is because the effect on production of varying patterns of substrate concentrations in the blood is mediated by network interactions at the level of secretory cell metabolism and microcirculation. However, dynamic modelling provides a rational framework for developing such predictive tools.

Predominant subpopulations of T lymphocytes in the mammary gland secretions during lactation and intraepithelial T lymphocytes in the intestine of dairy cows

Lymphocytes obtained from mammary gland secretions (MGS) during lactation or the dry period of dairy cows were simultaneously analyzed and compared to ileal intraepithelial lymphocytes (IEL) and peripheral blood lymphocytes (PBL) using monoclonal antibodies (mAb) specific for bovine leukocyte differentiation antigens. The T-lymphocytes of MGS during lactation and those in IEL were predominantly CD8 +, while T-cells in MGS during the dry period were predominantly CD4 +. In addition, the proportion of γ δ T-cells in MGS during lactation and IEL was fairly high. A large percentage of CD8 + cells and T-cells coexpressed the activation molecule, ACT2, yielding a high proportion of ACT2 + CD8 T-cells and ACT2 + γ δ T-cells, in MGS during lactation and IEL. However, both types of cells were found at an extremely low level in MGS during the dry period and in PBL. Thus, the predominant T-cell populations in MGS during lactation are phenotypically similar to those in IEL in the intestine.

乳牛の健康ならびに乳房炎乳房の乳汁中ブドウ球菌とその産生毒素の検出

To isolateStaphylococcus aureus (S. aureus) and coagulase-negative staphylococci (CNS), examinations were made of mammary-gland secretions (MGS) from healthy and mastitic dairy cows at different stages of lactation. In the MGS of healthy mammary glands, throughout both lactating and nonlactating periods, S. aureusand CNS were detected at high levels near those observed in chronically infected mammary glands. MGSs were examined also for incidence and concentration of such staphylococcal enterotoxins (SEs) as SEA, SEB, SEC, SED, and SEE and for toxic shock syndrome toxin-1 (TSST-1). These toxins were detected at levels of nearly 50% in cultures of bothS. aureusand CNS. In the MGSs, incidences and amounts of SEC, though of neither the other SEs nor TSST-1, correlated well with degree of mammary-gland inflammation. These results strongly suggest that SEC may participate as a causal agent in subclinical staphylococcal mammary-gland infection causing apparent mastitis.

A Phenotype of Mammary Intra-Epithelial Lymphocytes(mIEL) in Cows.

The phenotype of mammary intra−epithelial lymphocytes (mIEL) has not been described. In order to determine the potential role of mIEL to the mammary epithelial cells of cows, it is important to characterize these cells during the lactating periods. The phenotype of mIEL was analyzed using monoclonal antibodies to lymphocyte surface markers. In the alveolar epithelium of mammary glands, a higher percent of CD8+ mIEL was constituted of TCR1+ cells expressing γ/δ T cell receptor (γ/δ T cells) and ACT2+ cells expressing both activation markers of null cell and CD8+ T cell. Both γ/δ T cells and ACT2+ cells were preferentially distributed in the mammary epithelium. ACT2+ cells were about twice as many as γ/δ T cells. The ratio of CD4+/ CD8+ T cells was less than 0.3 in the alveolar epithelium. A quantitative cytological analysis by flow cytometry showed that lymphocytes isolated from mammary gland secretions (MGSLy) co−expressed CD8 and γ/δ T cell receptor, CD8 and ACT2 or ACT2 and γ/δ T cell receptor. The results suggest that CD8+ mIEL in cows coexpress γ/δ T cell receptor and/or ACT2.

Isolation of bovine mammary lymphocytes for fluorescent activated flow cytometry.

A detailed methodology is described for the isolation of T lymphocytes from bovine mammary gland secretions for flow cytometry. Mammary gland secretions are collected and centrifuged to separate the leukocytes from the mammary supernatant. The leukocytes are purified using a density gradient and diluted for fluorescent staining. Using tri-color fluorescent staining, the T lymphocytes are identified by monoclonal antibodies and stained with secondary antibodies. Flow cytometry is used to quantify the cellular subpopulations of the T lymphocytes. Proportional and statistical analysis of the flow cytometric data is conducted with computer software, CELLQuest and SAS.

Variation in CD4 + T and CD8 + T lymphocyte subpopulations in bovine mammary gland secretions during lactating and non-lactating periods

Mammary gland secretions (MGS) of dairy cows at different stages of lactation were studied by immunofluorescence cytometry for T lymphocyte subpopulations using monoclonal antibodies. During early and late lactation, the mean ratio of CD4 +/CD8 + T lymphocytes in the MGS was 0.5 and 0.8, respectively. A large proportion of the CD8 + cells coexpressed the activation molecule, ACT2. These results indicate that CD8 + ACT2 + cells constituted the major phenotype in the T lymphocytes throughout lactation. In the mammary gland of cows in which drying off was induced, however, the proportion of CD8 + ACT2 + cells decreased, resulting in the increase of the CD4 +/CD8 + ratio in the MGS. At the late non-lactation stage, the ratio reached a maximal level of 2.5–4.0, which was similar to or higher than that found in the peripheral blood. This selective increase of CD4 +/CD8 + cell ratio correlated with an increase in the concentrations of total cells in the MGS. This high CD4 +/CD8 + cell ratio during the drying off stage rapidly decreased just before parturition, correlating with the decrease in concentrations of total cells in the MGS, reaching the lowest level at early lactation. The cells isolated at the non-lactation stage produced the cytokines IL-2 and IL-4 at a level much higher than those of cells isolated at lactation stages, and the increases were correlated with the CD4 + T lymphocyte proportions.

Peptides Generated from Milk Proteins in the Bovine Mammary Gland During Involution

Proteolytic activity in mammary gland secretions is associated with hydrolysis of secretory proteins during involution. Peptides generated from hydrolysis of milk proteins were characterized in secretions from the bovine mammary gland during involution to understand the fate of the milk proteins better. Mass spectral analysis of mammary secretions showed numerous peptides ranging between 0.7 and 14 kDa during mammary involution, but these peptides were not observed in normal milk. Mass spectral profiles representing discrete peptide fragments were similar on d 7, 14, and 21 of involution, suggesting that milk proteins were only partially hydrolyzed during involution. N-Terminal amino acid sequences of four peptides indicated that they were produced by hydrolysis of β-casein during involution and probably resulted from plasmin hydrolysis. A 20-kDa peptide was identified as a fragment of a 39-kDa protein that was previously identified in bovine mammary secretions during involution. Mass spectral analysis of lactoferrin isolated from mammary secretions during involution showed major hydrolytic products. Immunoblot analysis confirmed that lactoferrin that was isolated from mammary secretions during involution contained a number of hydrolytic products. Intramammary hydrolysis of milk proteins by plasmin probably leads to the generation of the discrete peptides observed in the mammary secretions and contributes to the fate of these proteins during involution of the bovine mammary gland.

Protective factors in mammary gland secretions during the periparturient period in the mare

Summary Changes in mare mammary secretion composition were characterized prior to and after foaling. Eighteen mares were used for collection of mammary secretions from 23 days prepartum through 44 days postpartum. Concentrations of lactose, total protein, IgG and lysozyme (activity assay) were determined. Considerable variabilty was observed among mares. Mean lactose concentrations by mare were lower (P

Analysis of T lymphocyte subsets in bovine mammary gland secretions during the lactation cycle

Analysis of T lymphocyte subsets in bovine mammary gland secretions during the lactation cycle

Proteolysis of Milk Proteins During Involution of the Bovine Mammary Gland

The role of proteolytic hydrolysis of milk proteins in the mammary gland during involution is unknown. The objectives of this study were to determine the activities of plasmin, plasminogen, and plasminogen activator in mammary gland secretions collected during involution and to identify peptides generated by proteolysis of casein and lactoferrin in those secretions. Mammary secretions were collected from Holstein cows on d 7, 14, and 21 of involution and on d 7 postcalving. Activities of plasmin, plasminogen, and plasminogen activator were determined on the defatted, filtered aqueous phase of mammary secretions. Activities of plasmin, plasminogen, and plasminogen activator were significantly higher on d 7, 14, and 21 of involution than were those on d 7 postcalving. Protein fragments resulting from hydrolysis were detected by SDS-PAGE in samples collected on d 7, 14, and 21 of involution, but few protein fragments were observed in samples collected on d 7 postcalving when plasmin activity was low. Immunoblot analysis showed that a number of peptides observed during involution were generated from αs-casein (CN), β-CN, κ-CN, or lactoferrin. The appearance of peptides from proteins of mammary secretions during early involution was generally correlated with increased plasmin activity. Elevated plasmin activity during mammary involution may be primarily responsible for the observed concurrent hydrolysis of milk proteins in mammary secretions.

Immunobiology of the Mammary Gland

The mammary gland is a complex organ that provides neonatal offspring with milk for nourishment and disease resistance. Specific and innate immune factors associated with mammary gland tissues and secretion also play a vital role in protecting the gland from infectious disease. Through genetic selection and technological advances in milk removal, the bovine mammary gland yields far more milk than is needed to nourish the newborn calf. This excess is the basis of the dairy industry. Factors associated with the intense management of dairy cattle can profoundly affect mammary gland immunity and the ability of the host to resist mastitis. Technological advances in immunology have led to the availability of new research tools that can facilitate the study of mammary gland immunity and disease pathogenesis. In recent years, considerable research effort has focused on enhancing the natural defense mechanisms of the mammary gland during periods of heightened susceptibility to disease. This paper provides a comprehensive overview of mammary gland immunity with special emphasis on the bovine system. The underlying mechanisms of disease susceptibility and development of potential immunoregulatory strategies to control mastitis are discussed.

Prevalence of intramammary infections in primigravid Brazilian dairy heifers

Mammary-gland secretions from 467 quarters of 120 primigravid purebred and crossbred Holstein heifers from six dairy herds were collected; 96 (80%) of the heifers had intramammary infections and 57% of the quarters were infected. Staphylococcus spp. were isolated from 230 (49%) quarters. Other microorganisms commonly isolated from secretion samples were: Corynebacterium sp. (33 quarters, 7%) and Streptococcus (21 quarters, 4%). Enterobacteriaceae ( Escherichia coli, Klebsiella spp.) were isolated from eight (2%) samples.

Role of receptors for epidermal growth factor and insulin-like growth factors I and II in the differentiation of rat mammary glands from lactogenesis I to lactogenesis II.

In addition to ovarian steroids and lactogenic hormones from the placenta and pituitary, growth factors control the growth and differentiation of mammary glands. Lactogenesis II at the end of pregnancy is under the control of progesterone. Ovariectomy results in a significant decrease in the number of receptors for epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) and an increase in IGF-II binding sites in mammary gland acini of rats, without affecting the affinity for their respective ligand. Although concentrations of EGF, IGF-I and IGF-II receptors are regulated by oestradiol and progesterone, replacement treatment with ovarian steroids after ovariectomy showed that receptor concentrations do not mediate the restraint on lactogenesis. Progesterone treatment, which inhibits the onset of lactogenesis II, did not restore EGF receptor concentrations to control values, and the presence of oestradiol was required to reverse the effect of ovariectomy. Oestradiol, which potentiates the effect of ovariectomy on milk synthesis, increases IGF-I receptor concentrations. IGF-II receptor concentrations, after the different steroid treatments, were consistent with the steroid effect on milk synthesis. The changes observed in the concentrations of these growth factor receptors at the onset of mammary gland secretion are not considered to affect the progesterone block to lactogenesis II, but rather are a consequence of the shift of the hormonal and, hence, physiological status of the gland.

Developmental regulation and partial characterization of growth factors in the bovine mammary gland

Bovine mammary gland secretions from several developmental stages were shown to stimulate [3H]thymidine incorporation into AKR-2B mouse embryo fibroblast cells. In virgin heifers, mammary secretions at 1% concentration stimulated thymidine incorporation into AKR-2B cells more than threefold compared with 10% (v/v) fetal calf serum. The growth-promoting activity peaked at an early stage of the last trimester (7-8 months) of gestation and declined after this until the colostrum forming stage. At this point, the activity was one- to twofold that induced by 10% (v/v) fetal calf serum. At parturition the activity dropped abruptly to virtually undetectable values in milk. The developmental change in activity could be mimicked by hormonal priming of the mammary gland. The partial characterization of the growth promoting activities in secretions at the seventh month of gestation revealed at least two major growth-promoting activities: bovine mammary derived growth factor 1 (bMDGF-1), an epidermal growth factor-like growth factor with a molecular weight of 30,000, which is trypsin sensitive and heat stable, and bMDGF-2, which eluted under gel filtration conditions at a molecular weight of 50,000 and 150,000. bMDGF-1 is predominant in pregnant, precolostric, and colostric secretions, and is not detected in milk. bMDGF-2 is the major growth factor in milk. These results show developmental regulation and modulation of growth-promoting factors during the different stages of mammary gland development and suggest that growth factors are involved in regulating growth during gestation.